Latest Posts
Bad Leadership, From the Inbox to the Front LineSlow News, Busy DayEmpty Magazines, Full FirehouseThe Ants and the Rock: Notes From the Slowest News Week of the YearThe Deal and the DrugThe Show and the StoryA Scout Sniper Asked Me How to Fight Drones and Buehring Is a GraveyardThe War I Trained For Doesn’t Exist Anymore.Three Wars Nobody Is Connecting: Iran, Pakistan, and the Prison Break That Changes EverythingOperation Epic Fury, Day 20: The Domestic Threat Picture, the Economic Fallout, and the Intelligence Gaps That Are Not Getting CoverageWhen Drones Meet AI, Nobody's Ready: What Operation Epic Fury Is Teaching Us About the Next WarFollow the Money: Who's Getting Paid Off Operation Epic FuryWeek One of Epic Fury: Iran Is Running Out of Options. Watch Isfahan.Bad Leadership, From the Inbox to the Front LineSlow News, Busy DayEmpty Magazines, Full FirehouseThe Ants and the Rock: Notes From the Slowest News Week of the YearThe Deal and the DrugThe Show and the StoryA Scout Sniper Asked Me How to Fight Drones and Buehring Is a GraveyardThe War I Trained For Doesn’t Exist Anymore.Three Wars Nobody Is Connecting: Iran, Pakistan, and the Prison Break That Changes EverythingOperation Epic Fury, Day 20: The Domestic Threat Picture, the Economic Fallout, and the Intelligence Gaps That Are Not Getting CoverageWhen Drones Meet AI, Nobody's Ready: What Operation Epic Fury Is Teaching Us About the Next WarFollow the Money: Who's Getting Paid Off Operation Epic FuryWeek One of Epic Fury: Iran Is Running Out of Options. Watch Isfahan.
Evox Therapeutics Ltd
Delaware City, Delaware · 51-200 employees
Healthcare
About Evox Therapeutics Ltd.
Evox Therapeutics is redefining the treatment of genetically-driven neurodegenerative diseases by harnessing the power of next-generation genome editing technologies. Backed by leading investors and partners, Evox is advancing an innovative, proprietary pipeline with MSH3 for Huntington’s disease as our lead program, alongside ATXN2 for ALS and SCA2, while unlocking broader opportunities across genetic and non-genetic central nervous system diseases. We are dedicated to transforming patient outcomes through cutting-edge science and unparalleled therapeutic innovation.
Company information
Employees
51-200
Phone
4803194430
Location
Delaware City, Delaware, United States